(Q39584693)

English

PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs.

scientific article published on 28 February 2011

Statements

PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs. (English)
28 February 2011
3222-3233

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit